ทฌวัษ็ว๘app

Oncology/Hematology

News, opinions and meeting coverage in oncology/hematology.

TULSA Effective in Controlling Prostate Cancer Long-Term

โ€” At 5 years, median PSA was reduced by 90%

12 Hrs Ago
SUO over a photo of the Omni Shoreham Hotel in Washington, DC.

Latest in Oncology/Hematology

Rituximab Maintenance Boosts Survival for Older Adults With MRD-Negative MCL

Patients with treatment-sensitive disease may benefit most from continued treatment, says expert

Dec 05, 2023
After Chemo, Breast Cancer Patient Develops Two Malignant Neoplasms

Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge

Dec 04, 2023
Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS

40% of patients treated with imetelstat were transfusion-free for at least 8 weeks

Dec 04, 2023
'Watch and Wait' With Small Renal Masses: When and How Should Docs Intervene?

Phillip Pierorazio, MD, outlines how to be a good steward of active surveillance

Dec 04, 2023
Novel Therapy Reduced Transfusion Dependence in Lower-Risk MDS

40% of patients treated with imetelstat were transfusion-free for at least 8 weeks

'Watch and Wait' With Small Renal Masses: When and How Should Docs Intervene?

Phillip Pierorazio, MD, outlines how to be a good steward of active surveillance

Oncology/Hematology Case Studies

After Chemo, Breast Cancer Patient Develops Two Malignant Neoplasms

Be aware of the potential for secondary malignancy in relation to LCH diagnosis, researchers urge

A photo of a womanโ€™s hand on her skin, which is affected by a rash.
Patient's Colonoscopy Refusal Highlights Value of CRC Screening

Man with a first-degree relative with CRC initially only agreed to stool-based testing

A computer rendering of colorectal cancer.
What Caused a Man to Develop Friable Bleeding Nodules on His Arms and Hips?

The cause lies in a lengthy history of cancer treatment, confirmed by histopathology analysis

A photo composite of a man with arm sores.

More in Oncology/Hematology

First Gene Therapy for Non-Muscle-Invasive Bladder Cancer Offers Durable Response

A quarter patients with high-risk, BCG-unresponsive disease were recurrence free at 3 years

Dec 04, 2023
SUO over a photo of the Omni Shoreham Hotel in Washington, DC.
Non-Covalent BTK Inhibitor Approved for CLL

Response rates with pirtobrutinib reached 72% in heavily pretreated patient population

Dec 04, 2023
FDA APPROVED pirtobrutinib (Jaypirca) over a computer rendering of chronic lymphocytic leukemia cells.
Opinion
Charting the Course: From Young Adult Leukemia Patient to Oncologist

My experience shaped how I care for patients today

Dec 03, 2023
 A photo of a young female physician looking at MRI scans of her patientโ€™s brain.
Let's Talk Drug Prices; Restoring the Sense of Touch; Learning From Tumors in a Dish

News, features, and commentary about cancer-related issues

Dec 01, 2023
Onco Break over a computer rendering of a cancer cell.
Oncolytic Virus Shows High Response Rates in BCG-Unresponsive Bladder Cancer

Results from interim analysis suggest "potential to disrupt the NMIBC treatment landscape"

Dec 01, 2023
SUO over a photo of the Omni Shoreham Hotel in Washington, DC.
Year in Review: Follicular Lymphoma

A promising year for bispecific antibodies

Dec 01, 2023
YIR FOLLICULAR LYMPHOMA over a microscope image of follicular lymphoma.
Breast Cancer Screening Frequency Makes a Big Survival Difference

Keeping those mammogram appointments is life-saving, study finds

Nov 30, 2023
RSNA over a photo of McCormick Place South in Chicago, Illinois.
Noninvasive Therapy Shows Efficacy in Non-Muscle-Invasive Bladder Cancer

Investigational intravesical solution led to complete response rate of 79%

Nov 30, 2023
SUO over a photo of the Omni Shoreham Hotel in Washington, DC.
Combining Immunotherapy and PARP Inhibition in Advanced Uterine Cancer

And our roundtable of experts discuss selinexor for wild-type p53 disease

Nov 30, 2023
image
AI Model Can Predict Breast Cancer Risk Regardless of Patient's Race

Algorithm proved accurate where traditional risk models have failed, but needs more testing

Nov 30, 2023
RSNA over a photo of McCormick Place South in Chicago, Illinois.
With an Old X-Ray, AI Can Detect High Risk of Lung Cancer in Never Smokers

Tool could identify nonsmokers most likely to benefit from low-dose CT screening

Nov 29, 2023
RSNA over a photo of McCormick Place South in Chicago, Illinois.
FDA Investigating 'Serious Risk' of Malignancy After CAR-T Therapy

Applies to all approved therapies, but benefits still outweigh risks, agency says

Nov 28, 2023
A scanning electron microscope image of CAR-T cells attacking a cancer cell.
Mailing HPV Self-Sampling Kits to Patients Boosted Cervical Cancer Screening

The strategy was effective for patients who were due or overdue for screening

Nov 28, 2023
A photo of a cervical brush head in a sample collection container.
FDA Approves First Therapy for Progressive Desmoid Tumors

Nirogacestat reduced the risk of disease progression or death by 71% in randomized trial

Nov 28, 2023
FDA APPROVED nirogacestat (Ogsiveo) over a computer rendering of a connective tissue tumor.
More in Oncology/Hematology

Latest Meetings